Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results ...Middle East

PR Newswire - News
Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
CORAL GABLES, Fla., Aug. 11, 2022 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD) ("Relmada," the "Company," "we," "us, "our"), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today provided a corporate update and announced preliminary...

Read More Details
Finally We wish PressBee provided you with enough information of ( Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results )

Apple Storegoogle play

Also on site :



Latest News